Top Markets
Coin of the day
Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD
Ранг среди акций #30249
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages... Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
Цена акции
$1.88
Последняя синхронизация: 2026-08-18
Рыночная капитализация
$17.59M
Изменение (1 день)
0.81%
Изменение (1 год)
-92.40%
Страна
US
Торговля Tvardi Therapeutics, Inc. (TVRD)

Категория

История цены акций Tvardi Therapeutics, Inc. (TVRD)
Наивысшая цена закрытия: $1.83 2026-08-01

Наименьшая цена закрытия: $17.54 2025-04-01
История цены акций Tvardi Therapeutics, Inc. с 2025 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 100.99%
2025 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$527.89 35.09%
US
$996.61 51.72%
NL
$115.26 -20.82%
AU
$735.86 6.07%
CH
$1.06K -5.95%
KR